Inflammation and impaired adipogenesis in hypertrophic obesity in man.

Obesity is associated mainly with adipose cell enlargement in adult man (hypertrophic obesity), whereas the formation of new fat cells (hyperplastic obesity) predominates in the prepubertal age. Adipose cell size, independent of body mass index, is negatively correlated with whole body insulin sensitivity. Here, we review recent findings linking hypertrophic obesity with inflammation and a dysregulated adipose tissue, including local cellular insulin resistance with reduced IRS-1 and GLUT4 protein content. In addition, the number of preadipocytes in the abdominal subcutaneous adipose tissue capable of undergoing differentiation to adipose cells is reduced in hypertrophic obesity. This is likely to promote ectopic lipid accumulation, a well-known finding in these individuals and one that promotes insulin resistance and cardiometabolic risk. We also review recent results showing that TNFα, but not MCP-1, resistin, or IL-6, completely prevents normal adipogenesis in preadipocytes, activates Wnt signaling, and induces a macrophage-like phenotype in the preadipocytes. In fact, activated preadipocytes, rather than macrophages, may completely account for the increased release of chemokines and cytokines by the adipose tissue in obesity. Understanding the molecular mechanisms for the impaired preadipocyte differentiation in the subcutaneous adipose tissue in hypertrophic obesity is a priority since it may lead to new ways of treating obesity and its associated metabolic complications.

[1]  U. Smith,et al.  Impaired Preadipocyte Differentiation in Human Abdominal Obesity , 2009, Diabetes.

[2]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[3]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[4]  B. Zinman,et al.  Rosiglitazone-Associated Fractures in Type 2 Diabetes , 2008, Diabetes Care.

[5]  U. Smith,et al.  Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[6]  A. Häkkinen,et al.  Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance , 2007, Diabetologia.

[7]  M. Katoh,et al.  WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.

[8]  Kalyani V. P. Guntur,et al.  Tumor Necrosis Factor α (TNFα) Stimulates Map4k4 Expression through TNFα Receptor 1 Signaling to c-Jun and Activating Transcription Factor 2* , 2007, Journal of Biological Chemistry.

[9]  U. Smith,et al.  Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin. , 2007, Biochemical and biophysical research communications.

[10]  F. Heyd,et al.  Tumour necrosis factor-α inhibits adipogenesis via a β-catenin/TCF4(TCF7L2)-dependent pathway , 2007, Cell Death and Differentiation.

[11]  Georg Schett,et al.  Dickkopf-1 is a master regulator of joint remodeling , 2007, Nature Medicine.

[12]  O. MacDougald,et al.  Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.

[13]  K. Petersen,et al.  Etiology of insulin resistance. , 2006, The American journal of medicine.

[14]  U. Smith,et al.  Cytokines Promote Wnt Signaling and Inflammation and Impair the Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes* , 2006, Journal of Biological Chemistry.

[15]  Xiaoqing Tang,et al.  An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[17]  M. Katoh,et al.  WNT/PCP signaling pathway and human cancer (review). , 2005, Oncology reports.

[18]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[19]  O. MacDougald,et al.  Wnt Signaling Inhibits Adipogenesis through β-Catenin-dependent and -independent Mechanisms* , 2005, Journal of Biological Chemistry.

[20]  Charlotte A Peterson,et al.  Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. , 2005, Molecular biology of the cell.

[21]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[22]  K. Brennan,et al.  Wnt Proteins Induce Dishevelled Phosphorylation via an LRP5/6- Independent Mechanism, Irrespective of Their Ability To Stabilize β-Catenin , 2004, Molecular and Cellular Biology.

[23]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[24]  Nobuyuki Onishi,et al.  The receptor tyrosine kinase Ror2 is involved in non‐canonical Wnt5a/JNK signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  B. Spiegelman,et al.  Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity , 1999 .

[26]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[27]  F. Heyd,et al.  Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. , 2007, Cell death and differentiation.

[28]  Kalyani V. P. Guntur,et al.  Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. , 2007, The Journal of biological chemistry.

[29]  L. Pénicaud,et al.  Preadipocyte conversion to macrophage: evidence of plasticity , 2002 .

[30]  B. Spiegelman,et al.  Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. , 1999, Molecular cell.